26 phenotypes from 5 alleles in 6 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Klbem1(IMPC)J/Klb+ C57BL/6NJ-Klbem1(IMPC)J/Mmjax	decreased grip strength	J:211773
Klbem1(IMPC)J/Klbem1(IMPC)J C57BL/6NJ-Klbem1(IMPC)J/Mmjax	abnormal embryo size	J:211773
	abnormal placenta size	J:211773
	abnormal placenta vasculature	J:211773
	preweaning lethality, incomplete penetrance	J:211773
Klbtm1.1Akha/Klbtm1.1Akha C57BL/6-Klbtm1.1Akha	abnormal body fat mass	J:195570
	abnormal circulating adiponectin level	J:195570
	abnormal circulating cholesterol level	J:195570
	abnormal circulating glucose level	J:195570
	abnormal circulating insulin level	J:195570
	abnormal circulating ketone body level	J:195570
	abnormal circulating leptin level	J:195570
	abnormal energy expenditure	J:195570
	decreased circulating cholesterol level	J:195570
	decreased circulating insulin level	J:195570
	decreased susceptibility to weight loss	J:195570
Klbtm1.1Sakl/Klbtm1.1Sakl Tg(Camk2a-cre)2Gsc/0 involves: 129 * C57BL/6 * FVB/N * SJL	normal growth/size/body region phenotype	J:189018
	normal homeostasis/metabolism phenotype	J:189018
Klbtm1.1Sakl/Klbtm1.1Sakl Tg(Fabp4-cre)1Rev/0 involves: 129 * C57BL/6 * SJL	abnormal adipose tissue physiology	J:189018
	abnormal glucose homeostasis	J:189018
	increased insulin sensitivity	J:189018
Klbtm1.2Sakl/Klbtm1.2Sakl involves: 129 * 129S4/SvJaeSor * C57BL/6	abnormal glucose homeostasis	J:189018
	decreased body weight	J:189018
	decreased circulating triglyceride level	J:189018
Klbtm1Yin/Klbtm1Yin involves: C57BL/6 * CBA	abnormal bile salt homeostasis	J:100209
	abnormal liver physiology	J:100209
	decreased body weight	J:100209
	small gallbladder	J:100209